Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat
- PMID: 20107719
- DOI: 10.2340/00015555-0789
Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat
Abstract
Pruritus has a well-known association with Hodgkin's disease and other nodal lymphomas; indeed it often reveals the disease. Pruritus is also an important symptom of cutaneous T-cell lymphomas. Lymphoma-associated itch is thus both frequent and severe, but its pathophysiology remains unclear. Few studies have evaluated the efficacy of therapeutic agents in the management of cutaneous T-cell lymphoma-related pruritus. The main objective of treatment remains disease control. Pruritus management is generally based on the physician's experience. Treatment is very difficult, especially in Sézary syndrome. We present here management strategies for cutaneous lymphoma-associated pruritus.
Similar articles
-
What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus.Am J Clin Dermatol. 2024 Jan;25(1):67-77. doi: 10.1007/s40257-023-00823-2. Epub 2023 Nov 16. Am J Clin Dermatol. 2024. PMID: 37971624 Review.
-
Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma.J Am Acad Dermatol. 2006 Sep;55(3):543-4. doi: 10.1016/j.jaad.2006.04.025. J Am Acad Dermatol. 2006. PMID: 16908377 No abstract available.
-
Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.Br J Dermatol. 2018 Apr;178(4):e273-e274. doi: 10.1111/bjd.16128. Epub 2018 Feb 22. Br J Dermatol. 2018. PMID: 29150837 No abstract available.
-
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.Cancer Treat Rev. 2007 Apr;33(2):146-60. doi: 10.1016/j.ctrv.2006.08.006. Epub 2007 Feb 1. Cancer Treat Rev. 2007. PMID: 17275192 Review.
-
High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.Arch Dermatol. 1995 May;131(5):574-9. Arch Dermatol. 1995. PMID: 7741545
Cited by
-
"Knock Me Out": The Challenges of Managing Pain Due to Cutaneous T Cell Lymphomas: A Case Report.J Palliat Med. 2022 Nov;25(11):1740-1746. doi: 10.1089/jpm.2021.0561. Epub 2022 Apr 13. J Palliat Med. 2022. PMID: 35420490 Free PMC article.
-
Sympathetic Nerve Mediated Spinal Glia Activation Underlies Itch in a Cutaneous T-Cell Lymphoma Model.Neurosci Bull. 2022 Apr;38(4):435-439. doi: 10.1007/s12264-021-00805-6. Epub 2021 Dec 6. Neurosci Bull. 2022. PMID: 34870787 Free PMC article. No abstract available.
-
Health-related quality of life and economic implications of cutaneous T-cell lymphoma.Br J Dermatol. 2020 Jan;182(1):190-196. doi: 10.1111/bjd.17941. Epub 2019 Aug 6. Br J Dermatol. 2020. PMID: 30920642 Free PMC article.
-
IL-31 and IL-8 in Cutaneous T-Cell Lymphoma: Looking for Their Role in Itch.Adv Hematol. 2021 Jul 20;2021:5582581. doi: 10.1155/2021/5582581. eCollection 2021. Adv Hematol. 2021. PMID: 34335777 Free PMC article.
-
An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.Clin Exp Med. 2023 Dec;23(8):4177-4197. doi: 10.1007/s10238-023-01141-x. Epub 2023 Aug 9. Clin Exp Med. 2023. PMID: 37555911 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials